Article
Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects.
Microbiology spectrum - 6 Feb 2024
Elko Evan A, Mead Heather L, Nelson Georgia A, Zaia John A, Ladner Jason T, Altin John A
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages of the Omicron variant rapidly became dominant in early 2022 and frequently cause human infections despite vaccination or prior infection with other variants. In addition to antibody-evading mutations in the receptor-binding domain, Omicron features amino acid mutations elsewhere in the Spike protein; however, their effects generally remain ill...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
